Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 5
1976 1
1977 4
1978 16
1979 12
1980 287
1981 671
1982 840
1983 752
1984 885
1985 951
1986 1055
1987 1210
1988 1320
1989 1481
1990 1562
1991 1637
1992 1776
1993 1945
1994 2073
1995 2179
1996 2331
1997 2492
1998 2561
1999 2580
2000 2766
2001 2897
2002 3156
2003 3532
2004 3856
2005 4545
2006 5006
2007 5430
2008 6242
2009 7071
2010 7862
2011 8518
2012 9034
2013 9528
2014 9834
2015 9708
2016 9681
2017 9742
2018 9952
2019 10538
2020 12746
2021 14201
2022 13937
2023 13881
2024 2947

Text availability

Article attribute

Article type

Publication date

Search Results

201,749 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: sokhwatul
Page 1
Showing results for sokhwatul ag nia
Search for Sokhwatul Aghnia instead (3 results)
Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
Fischer ES, Böhm K, Lydeard JR, Yang H, Stadler MB, Cavadini S, Nagel J, Serluca F, Acker V, Lingaraju GM, Tichkule RB, Schebesta M, Forrester WC, Schirle M, Hassiepen U, Ottl J, Hild M, Beckwith RE, Harper JW, Jenkins JL, Thomä NH. Fischer ES, et al. Nature. 2014 Aug 7;512(7512):49-53. doi: 10.1038/nature13527. Epub 2014 Jul 16. Nature. 2014. PMID: 25043012 Free PMC article.
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.
Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. Dave CV, et al. Ann Intern Med. 2019 Aug 20;171(4):248-256. doi: 10.7326/M18-3136. Epub 2019 Jul 30. Ann Intern Med. 2019. PMID: 31357213 Free PMC article.
OBJECTIVE: To assess whether patients initiating use of SGLT-2 inhibitors were at increased risk for severe UTI events compared with those initiating use of dipeptidyl peptidase-4 (DPP-4) inhibitors or glucagon-like peptide-1 receptor (GLP-1) agonists. DESIGN: Population-b …
OBJECTIVE: To assess whether patients initiating use of SGLT-2 inhibitors were at increased risk for severe UTI events compared with those i …
Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.
Salameh TS, Rhea EM, Talbot K, Banks WA. Salameh TS, et al. Biochem Pharmacol. 2020 Oct;180:114187. doi: 10.1016/j.bcp.2020.114187. Epub 2020 Aug 2. Biochem Pharmacol. 2020. PMID: 32755557 Free PMC article.
Among the more promising treatments proposed for Alzheimer's disease (AD) and Parkinson's disease (PD) are those reducing brain insulin resistance. The antidiabetics in the class of incretin receptor agonists (IRAs) reduce symptoms and brain pathology in animal models of A …
Among the more promising treatments proposed for Alzheimer's disease (AD) and Parkinson's disease (PD) are those reducing brain insulin resi …
D-Serine, the Shape-Shifting NMDA Receptor Co-agonist.
Coyle JT, Balu D, Wolosker H. Coyle JT, et al. Neurochem Res. 2020 Jun;45(6):1344-1353. doi: 10.1007/s11064-020-03014-1. Epub 2020 Mar 18. Neurochem Res. 2020. PMID: 32189130 Free PMC article. Review.
Scientific rationale for the use of alpha2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders.
Arnsten AFT, Ishizawa Y, Xie Z. Arnsten AFT, et al. Mol Psychiatry. 2023 Nov;28(11):4540-4552. doi: 10.1038/s41380-023-02057-4. Epub 2023 Apr 7. Mol Psychiatry. 2023. PMID: 37029295 Free PMC article. Review.
However, the production of GCPII inflammatory signaling reduces mGluR3 actions and markedly diminishes dlPFC network firing. Both basic and clinical studies show that alpha2A-AR agonists such as guanfacine can restore dlPFC network firing and cognitive function, through di …
However, the production of GCPII inflammatory signaling reduces mGluR3 actions and markedly diminishes dlPFC network firing. Both basic and …
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review.
Cooper DH, Ramachandra R, Ceban F, Di Vincenzo JD, Rhee TG, Mansur RB, Teopiz KM, Gill H, Ho R, Cao B, Lui LMW, Jawad MY, Arsenault J, Le GH, Ramachandra D, Guo Z, McIntyre RS. Cooper DH, et al. J Psychiatr Res. 2023 Aug;164:80-89. doi: 10.1016/j.jpsychires.2023.05.041. Epub 2023 Jun 5. J Psychiatr Res. 2023. PMID: 37331261 Review.
GLP-1 receptor agonists have also been shown to have neuroprotective and antidepressant properties. ...Future research should focus on better elucidating the neuroprotective potential of different classes and doses of GLP-1 receptor agonists using controlled trials. …
GLP-1 receptor agonists have also been shown to have neuroprotective and antidepressant properties. ...Future research should focus o …
201,749 results
You have reached the last available page of results. Please see the User Guide for more information.